HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Clinical trials for HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY trials appear
Sign up with your email to follow new studies for HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy tested for patients too sick for standard chemo
Disease control OngoingThis early-phase study is testing the safety and side effects of combining a new oral drug called tolinapant with standard radiation therapy. It is for patients with locally advanced head and neck cancer who have not had prior treatment and cannot receive the usual chemotherapy d…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: EARLY_PHASE1 • Sponsor: Emory University • Aim: Disease control
Last updated Apr 04, 2026 10:20 UTC
-
Scientists test new weapon to boost cancer treatment
Disease control OngoingThis early-stage study is testing whether adding an experimental drug called berzosertib to standard chemotherapy (cisplatin) and radiation can better treat advanced head and neck cancer. The main goals are to find the safest and most effective dose of this new combination and to…
Matched conditions: HEAD AND NECK CARCINOMA OF UNKNOWN PRIMARY
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC